36 results
8-K
EX-1.1
AKRO
Akero Therapeutics Inc
6 Mar 24
Entry into a Material Definitive Agreement
5:25pm
) Certain Environmental Matters. (i) The Company and its subsidiaries (x) are in compliance with all, and have not violated any, applicable federal … or wastes, pollutants or contaminants (collectively, “Environmental Laws”); (y) have received and are in compliance with all, and have not violated
8-K
EX-1.1
mv7xb5sit4lwcju9nuwy
17 May 23
Akero Therapeutics Announces Pricing of $220.0 Million Underwritten Offering of Common Stock
5:01pm
8-K
EX-1.1
z6ms8xo nu
16 Sep 22
Entry into a Material Definitive Agreement
4:02pm
8-K
EX-10.1
p9nfkor1yporrzx9
16 Jun 22
Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million
7:14am
S-3ASR
EX-1.2
b16vzzju0t7zrw
18 May 21
Automatic shelf registration
6:01am